Department of Medical Physics and Clinical Engineering, Saint Vincent's University Hospital, Dublin, Ireland. Author to whom any correspondence should be addressed.
Phys Med Biol. 2018 Jan 26;63(3):035013. doi: 10.1088/1361-6560/aa9ea7.
Daylight photodynamic therapy (dl-PDT) is as effective as conventional PDT (c-PDT) for treating actinic keratoses but has the advantage of reducing patient discomfort significantly. Topical dl-PDT and white light-PDT (wl-PDT) differ from c-PDT by way of light sources and methodology. We measured the variables associated with light dose delivery to skin surface and influence of geometry using a radiometer, a spectral radiometer and an illuminance meter. The associated errors of the measurement methods were assessed. The spectral and spatial distribution of the radiant energy from the LED white light source was evaluated in order to define the maximum treatment area, setup and treatment protocol for wl-PDT. We compared the data with two red LED light sources we use for c-PDT. The calculated effective light dose is the product of the normalised absorption spectrum of the photosensitizer, protoporphyrin IX (PpIX), the irradiance spectrum and the treatment time. The effective light dose from daylight ranged from 3 ± 0.4 to 44 ± 6 J cmdue to varying weather conditions. The effective light dose for wl-PDT was reproducible for treatments but it varied across the treatment area between 4 ± 0.1 J cm at the edge and 9 ± 0.1 J cm centrally. The effective light dose for the red waveband (615-645 nm) was 0.42 ± 0.05 J cm on a clear day, 0.05 ± 0.01 J cm on an overcast day and 0.9 ± 0.01 J cm using the white light. This compares with 0.95 ± 0.01 and 0.84 ± 0.01 J cm for c-PDT devices. Estimated errors associated with indirect determination of daylight effective light dose were very significant, particularly for effective light doses less than 5 J cm (up to 83% for irradiance calculations). The primary source of error is in establishment of the relationship between irradiance or illuminance and effective dose. Use of the O'Mahoney model is recommended using a calibrated logging illuminance meter with the detector in the plane of the treatment area.
日光光动力疗法(dl-PDT)在治疗光化性角化病方面与传统 PDT(c-PDT)同样有效,但具有显著减少患者不适的优点。局部 dl-PDT 和白光-PDT(wl-PDT)与 c-PDT 的区别在于光源和方法。我们使用辐射计、光谱辐射计和照度计测量与皮肤表面光剂量传递相关的变量,并评估几何形状的影响。评估了测量方法的相关误差。评估了 LED 白光光源的辐射能量的光谱和空间分布,以便为 wl-PDT 定义最大治疗区域、设置和治疗方案。我们将这些数据与我们用于 c-PDT 的两个红色 LED 光源进行了比较。计算出的有效光剂量是光敏剂原卟啉 IX(PpIX)的归一化吸收光谱、辐照度光谱和治疗时间的乘积。由于天气条件的不同,日光的有效光剂量范围为 3 ± 0.4 至 44 ± 0.6 J cm。对于 wl-PDT,有效光剂量在治疗过程中是可重复的,但在治疗区域内,边缘处为 4 ± 0.1 J cm,中心处为 9 ± 0.1 J cm。在晴天,红色波段(615-645nm)的有效光剂量为 0.42 ± 0.05 J cm,阴天为 0.05 ± 0.01 J cm,使用白光时为 0.9 ± 0.01 J cm。相比之下,c-PDT 设备的有效光剂量为 0.95 ± 0.01 和 0.84 ± 0.01 J cm。间接确定日光有效光剂量相关的估计误差非常大,特别是对于小于 5 J cm 的有效光剂量(辐照度计算高达 83%)。误差的主要来源是确定辐照度或照度与有效剂量之间的关系。建议使用经过校准的记录照度计,将探测器置于治疗区域的平面内,使用 O'Mahoney 模型。